SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 127 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $27,673,000 | +31.1% | 1,841,035 | +6.2% | 1.57% | +31.1% |
| Q1 2016 | $21,103,000 | -5.2% | 1,733,987 | +23.9% | 1.20% | +22.3% |
| Q4 2015 | $22,261,000 | +22.8% | 1,399,205 | +18.3% | 0.98% | +2.8% |
| Q3 2015 | $18,130,000 | -40.2% | 1,182,633 | -5.2% | 0.96% | -23.7% |
| Q2 2015 | $30,325,000 | +51.7% | 1,247,428 | +45.1% | 1.25% | +58.6% |
| Q1 2015 | $19,992,000 | +116.5% | 859,872 | +133.8% | 0.79% | +103.4% |
| Q4 2014 | $9,234,000 | -53.1% | 367,758 | -41.9% | 0.39% | -52.8% |
| Q3 2014 | $19,676,000 | +17.8% | 632,675 | -2.1% | 0.82% | +27.0% |
| Q2 2014 | $16,707,000 | +5.7% | 646,049 | -4.4% | 0.65% | +7.7% |
| Q1 2014 | $15,801,000 | -9.0% | 676,111 | -1.2% | 0.60% | -3.7% |
| Q4 2013 | $17,361,000 | +383.6% | 684,054 | +288.7% | 0.62% | +318.8% |
| Q3 2013 | $3,590,000 | -15.3% | 175,968 | -12.9% | 0.15% | -14.4% |
| Q2 2013 | $4,239,000 | – | 202,031 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|